Diabetes drug metformin may help keep leukemia in remission
NCT ID NCT07188740
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This early-phase study tests whether metformin, a common diabetes medicine, can reduce levels of a specific gene mutation (DNMT3A R882) in 30 adults with acute leukemia who are in remission. Participants take metformin pills for 6 months. The goal is to see if the mutation drops enough to lower the chance of leukemia returning. This is not a cure, but a way to control the disease and prevent relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DNMT3A GENE MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.